Anti-Inflammatory Reliever South Africa
NCT06429475
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
1038
Enrollment
OTHER
Sponsor class
Conditions
Asthma
Interventions
DRUG:
Budesonide/formoterol
DRUG:
standard of care
Sponsor
University of KwaZulu